Cargando…

Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia

BACKGROUND AND AIMS: The individual‐level effectiveness of opioid agonist treatment (OAT) in reducing mortality is well established, but there is less evidence on population‐level benefits. We use modeling informed with linked data from the OAT program in New South Wales (NSW), Australia, to estimat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaillon, Antoine, Bharat, Chrianna, Stone, Jack, Jones, Nicola, Degenhardt, Louisa, Larney, Sarah, Farrell, Michael, Vickerman, Peter, Hickman, Matthew, Martin, Natasha K., Bórquez, Annick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299987/ https://www.ncbi.nlm.nih.gov/pubmed/34729841 http://dx.doi.org/10.1111/add.15736

Ejemplares similares

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia
por: Brothers, Thomas D., et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
por: Stone, Jack, et al.
Publicado: (2022)

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
por: Gisev, Natasa, et al.
Publicado: (2023)

Five-Year Trajectories of Prescription Opioid Use
por: Gisev, Natasa, et al.
Publicado: (2023)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
por: Ferraro, Claire F., et al.
Publicado: (2021)

Estimating the number of people who inject drugs in Australia
por: Larney, Sarah, et al.
Publicado: (2017)

The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas
por: Warfield, Sara C., et al.
Publicado: (2021)

Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol
por: Gisev, Natasa, et al.
Publicado: (2018)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis
por: Marks, Charles, et al.
Publicado: (2019)

The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study
por: Stone, Jack, et al.
Publicado: (2022)

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients
por: Zahra, Emma, et al.
Publicado: (2022)

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
por: MacArthur, Georgie J, et al.
Publicado: (2012)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia
por: Day, Carolyn, et al.
Publicado: (2005)

Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians
por: Gisev, Natasa, et al.
Publicado: (2014)

Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
por: Degenhardt, Louisa, et al.
Publicado: (2005)

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023)

Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation
por: Islam, M Mofizul, et al.
Publicado: (2018)

A cross-sectional survey of prevalence and correlates of suicidal ideation and suicide attempts among prisoners in New South Wales, Australia
por: Larney, Sarah, et al.
Publicado: (2012)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Assessing the contribution of alcohol‐specific causes to socio‐economic inequalities in mortality in England and Wales 2001–16
por: Angus, Colin, et al.
Publicado: (2020)

Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study
por: Campbell, Gabrielle, et al.
Publicado: (2014)

The stability of ethnic identity in England and Wales 2001–2011
por: Simpson, Ludi, et al.
Publicado: (2016)

Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times
por: Vo, Anh Truc, et al.
Publicado: (2022)

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis
por: Hines, Lindsey A, et al.
Publicado: (2019)

Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
por: Ling, R., et al.
Publicado: (2022)

Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?
por: Nielsen, Suzanne, et al.
Publicado: (2022)

Socioeconomic, remoteness and sex differences in life expectancy in New South Wales, Australia, 2001–2012: a population-based study
por: Stephens, Alexandre S, et al.
Publicado: (2017)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

People engaged in opioid agonist treatment as a counterpublic during the COVID‐19 pandemic in Australia: A qualitative study
por: Conway, Anna, et al.
Publicado: (2022)

Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia
por: Curtis, Michael, et al.
Publicado: (2023)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r9ofcneg2i7qrrp6pd9ivg7e9p